BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Al-Kuraishy HM, Al-Gareeb AI, Mostafa-Hedeab G, Kasozi KI, Zirintunda G, Aslam A, Allahyani M, Welburn SC, Batiha GE. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19. Front Immunol 2021;12:749291. [PMID: 34867978 DOI: 10.3389/fimmu.2021.749291] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Ivanov E, Akhmetshina M, Erdiakov A, Gavrilova S. Sympathetic System in Wound Healing: Multistage Control in Normal and Diabetic Skin. IJMS 2023;24:2045. [DOI: 10.3390/ijms24032045] [Reference Citation Analysis]
2 Wołowiec Ł, Grześk G, Osiak J, Wijata A, Mędlewska M, Gaborek P, Banach J, Wołowiec A, Głowacka M. Beta-blockers in cardiac arrhythmias-Clinical pharmacologist's point of view. Front Pharmacol 2022;13:1043714. [PMID: 36699057 DOI: 10.3389/fphar.2022.1043714] [Reference Citation Analysis]
3 Nadwa EH, Al-Kuraishy HM, Al-Gareeb AI, Elekhnawy E, Albogami SM, Alorabi M, Batiha GE, De Waard M. Cholinergic dysfunction in COVID-19: frantic search and hoping for the best. Naunyn Schmiedebergs Arch Pharmacol 2023;396:453-68. [PMID: 36460816 DOI: 10.1007/s00210-022-02346-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li N, Chen J, Xie S, Zhang M, Shi T, He Y, Jie Z, Su X. Oral antibiotics relieve allergic asthma in post-weaning mice via reducing iNKT cells and function of ADRB2. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1024235] [Reference Citation Analysis]
5 Al-Kuraishy HM, Issa HK, Al-Gareeb AI, El-Bouseary MM, Youssef A, Abdelaziz AS, Khalifa HA, Batiha GE. The role of ivabradine in doxorubicin-induced cardiotoxicity: exploring of underlying argument. Inflammopharmacology 2022. [PMID: 36219320 DOI: 10.1007/s10787-022-01082-z] [Reference Citation Analysis]
6 Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Batiha GE. Central Effects of Ivermectin in Alleviation of Covid-19-induced Dysauto-nomia. Curr Drug Targets 2022;23:1277-87. [PMID: 35950254 DOI: 10.2174/1389450123666220810102406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Al-Kuraishy HM, Al-Buhadily AK, Al-Gareeb AI, Alorabi M, Hadi Al-Harcan NA, El-Bouseary MM, Batiha GE. Citicoline and COVID-19: vis-à-vis conjectured. Naunyn Schmiedebergs Arch Pharmacol 2022. [PMID: 36063198 DOI: 10.1007/s00210-022-02284-6] [Reference Citation Analysis]
8 Al-Thomali AW, Al-Kuraishy HM, Al-Gareeb AI, K Al-Buhadiliy A, De Waard M, Sabatier JM, Khan Khalil AA, Saad HM, Batiha GE. Role of Neuropilin 1 in COVID-19 Patients with Acute Ischemic Stroke. Biomedicines 2022;10:2032. [PMID: 36009579 DOI: 10.3390/biomedicines10082032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Cadegiani FA. Catecholamines Are the Key Trigger of COVID-19 mRNA Vaccine-Induced Myocarditis: A Compelling Hypothesis Supported by Epidemiological, Anatomopathological, Molecular, and Physiological Findings. Cureus 2022. [DOI: 10.7759/cureus.27883] [Reference Citation Analysis]
10 Czura CJ, Bikson M, Charvet L, Chen JDZ, Franke M, Fudim M, Grigsby E, Hamner S, Huston JM, Khodaparast N, Krames E, Simon BJ, Staats P, Vonck K. Neuromodulation Strategies to Reduce Inflammation and Improve Lung Complications in COVID-19 Patients. Front Neurol 2022;13:897124. [DOI: 10.3389/fneur.2022.897124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Mostafa-Hedeab G, Al-Kuraishy HM, Al-Gareeb AI, Welson NN, El-Saber Batiha G, Conte-Junior CA. Selinexor and COVID-19: The Neglected Warden. Front Pharmacol 2022;13:884228. [PMID: 35559257 DOI: 10.3389/fphar.2022.884228] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
12 Al-Kuraishy HM, Al-Gareeb AI, Al-Hussaniy HA, Al-Harcan NAH, Alexiou A, Batiha GE. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality. Int Immunopharmacol 2022;104:108516. [PMID: 35032828 DOI: 10.1016/j.intimp.2021.108516] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 30.0] [Reference Citation Analysis]
13 Dunja L, Ivan P, Željko R. Interaction of Anti-COVID-19 Drugs with Cardiovascular Therapy. Contemporary Cardiology 2022. [DOI: 10.1007/978-3-031-15478-2_15] [Reference Citation Analysis]